A randomized, parallel group, double-blind study of ticagrelor compared with aspirin for prevention of vascular events in patients undergoing coronary artery bypass graft operation: Rationale and design of the Ticagrelor in CABG (TiCAB) trial: An Investigator-Initiated trial

A de Waha, S Sandner, M von Scheidt, A Boening, K Koch-Buettner, D Hammel, R Hambrecht, BC Danner, FA Schondube, G Goerlach, Theodor Fischlein (Co-author), M Schmoeckel, M Oberhoffer, R Schulz, T Walther, T Ziegelhoffer, C Knosalla, F Schonrath, F Beyersdorf, M SiepeT Attmann, M Misfeld, FW Mohr, HH Sievers, A Joost, LM Putman, G Laufer, C Hamm, U Zeymer, A Kastrati, PW Radke, R Lange, J Cremer, H Schunkert

Research output: Contribution to journalOriginal Articlepeer-review

18 Citations (Web of Science)
Original languageEnglish
Pages (from-to)69-76
JournalAMERICAN HEART JOURNAL
Volume179
DOIs
Publication statusPublished - 2016

Keywords

  • PLATELET INHIBITION
  • CLINICAL-TRIALS
  • OUTCOMES TRIAL
  • CLOPIDOGREL
  • SURGERY
  • THERAPY
  • DISEASE

Cite this